Recent advances in multifunctional dendrimer‐based complexes for cancer treatment

D Shcharbin, V Zhogla, V Abashkin… - Wiley …, 2024 - Wiley Online Library
The application of nanotechnology in biological and medical fields have resulted in the
creation of new devices, supramolecular systems, structures, complexes, and composites …

Macromolecules incorporating transition metals in the treatment and detection of cancer and infectious diseases: Progress over the last decade

A Abd-El-Aziz, SA Ahmed, X Zhang, N Ma… - Coordination Chemistry …, 2024 - Elsevier
The past decade has seen tremendous demand for the production of new materials based
on metal-containing macromolecules. Many research groups have dedicated their time and …

Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: A preliminary study

S Michlewska, M Maly, D Wojkowska… - International Journal of …, 2023 - Elsevier
Abstract The carbosilane metallodendrimer G 1-[[NCPh (oN) Ru (η6-p-cymene) Cl] Cl] 4
(CRD13), based on an arene Ru (II) complex coordinated to imino-pyridine surface groups …

[HTML][HTML] Ruthenium metallodendrimer against triple-negative breast cancer in mice

S Michlewska, D Wójkowska, C Watala, E Skiba… - … , Biology and Medicine, 2023 - Elsevier
Carbosilane metallodendrimers, based on the arene Ru (II) complex (CRD13) and
integrated to imino-pyridine surface groups have been investigated as an anticancer agent …

Target-Specific Delivery and Bioavailability of Pharmaceuticals via Janus and Dendrimer Particles

J Jeevanandam, KX Tan, J Rodrigues, MK Danquah - Pharmaceutics, 2023 - mdpi.com
Nanosized Janus and dendrimer particles have emerged as promising nanocarriers for the
target-specific delivery and improved bioavailability of pharmaceuticals. Janus particles, with …

Anticancer Potential of Dendritic Poly (aryl ether)-Substituted Polypyridyl Ligand-Based Ruthenium (II) Coordination Entities

L Raju, S Javan Nikkhah, MC K… - ACS Applied Bio …, 2023 - ACS Publications
This paper studies the anticancer potency of dendritic poly (aryl ether)-substituted
polypyridyl ligand-based ruthenium (II) coordination entities. The dendritic coordination …

Dissimilar effect of organometallic ruthenium complexes on the viability of MDR and non-MDR experimental models

S Opačak, MP Kovač, C Landais, Ž Debeljak… - Journal of inorganic …, 2024 - Elsevier
Ruthenium complexes containing triphenylphosphine diamide ligands were prepared,
characterized, and tested for their biological activity against various cancer cell lines and the …

Biological Effects in Cancer Cells of Mono-and Bidentate Conjugation of Cisplatin on PAMAM Dendrimers: A Comparative Study

C Camacho, D Maciel, H Tomás, J Rodrigues - Pharmaceutics, 2023 - mdpi.com
Cisplatin (cis-diamminedichloroplatinum (II)) is a potent chemotherapeutic agent commonly
used to treat cancer. However, its use also leads to serious side effects, such as …

[PDF][PDF] Initial version before any revisions

D Shcharbin, V Zhogla, V Abashkin, Y Gao, JP Majoral… - researchgate.net
The application of nanotechnology in biology and medicine induced the appearance of new
devices, supramolecular systems, structures, complexes and composites. Dendrimers are …

Bis (2, 2'-Bipyridine)(Salphen) Ruthenium (Ii) Complexes-Interaction with Serum Albumins and Anticancer Activity

V Gomathi Sankareswari, A Saravanan… - … and Balakrishnan, K … - papers.ssrn.com
The interaction of a series of [bis (2, 2'–bipyridine)(salphen) ruthenium (II)] complexes with
human serum albumin (HSA) and bovine serum albumin (BSA) studied by UV− vis …